Rodgers Richard J

Rodgers Richard J is listed in filings as Director at Opus Genetics, Inc.. This profile follows SEC Form 4 activity through Apr 22, 2026, including 17 public disclosures. Recent filings connect the profile to Opus Genetics, Inc. (IRD), Novavax, Inc. (NVAX), and Ardelyx, Inc. (ARDX). The current snapshot covers public activity from Jun 14, 2024 to Apr 22, 2026. Reported amounts are shown as $181.9K to $75.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.